Brief: Genocea Biosciences Inc Has Entered Into Research And Development Collaboration And Option Agreement With Janssen Biotech Inc
04/01/2022 12:14
Jan 4 (Reuters) - Genocea Biosciences Inc GNCA.O :
* GENOCEA BIOSCIENCES INC - HAS ENTERED INTO AN RESEARCH AND
DEVELOPMENT COLLABORATION AND OPTION AGREEMENT WITH JANSSEN
BIOTECH, INC.
* GENOCEA BIOSCIENCES INC - UNDER DEAL, CO WILL USE ITS
ATLAS
PLATFORM TO CHARACTERIZE JANSSEN-IDENTIFIED ANTIGENS
* GENOCEA BIOSCIENCES INC - UNDER DEAL, CO WILL ASSESS
APPROACHES
THAT COULD MITIGATE IMPACT OF INHIBIGENS
* GENOCEA BIOSCIENCES -DEAL HAS OPTION FOR JANSSEN TO
NEGOTIATE
FUTURE PARTNERSHIP TO DEVELOP NON-PERSONALIZED VACCINE PRODUCTS
WITH CO'S ATLAS PLATFORM
Source text for Eikon: ID:nGNX8c4Pc9
Further company coverage: GNCA.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Genocea Biosciences
See all newsBluebird, Chimerix, Clovis have under 6 months of cash left - Truist
Genocea Biosciences plunges as it winds down operations
Brief: Genocea Announces Wind Down Of Operations And Delisting From Nasdaq
Genocea Biosciences Inc reports results for the quarter ended in March - Earnings Summary
U.S. STOCKS ON THE MOVE-Oppenheimer Holdings, IES Holdings Inc, Avantor Inc